Limbix Logo


Digital therapeutics for adolescent mental health.





Palo Alto, California



Company Description

Limbix was acquired by Big Health. Limbix is passionate about delivering mental health treatment to young people who need it the most, when they need it the most. Our team is uniquely suited to develop prescription digital therapeutics, as we understand the value of pairing clinical expertise with technological innovation. Our diverse team of clinicians, product designers, researchers, and engineers are all focused on one thing: improving the lives of teens through accessible mental health treatment.

Quick Links



Total Raised

$31 million



Significant Investors

Sequoia Capital, GSR Ventures, Storm Ventures, Pacific Health Ventures, Mana Ventures, Operator Partners, Gaingels, DN Capital, NextGen Venture Partners

Company Traction

  • Limbix’s product, SparkRx, showed a clinically meaningful reduction in depression symptoms (≥ 5 point symptom reduction across the intervention) when sampling 63 patients with moderate to severe depression symptoms against a control group.
  • Limbix’s product, SparkRx, led to a statistically significant reduction in depression symptoms compared to the active control when sampling 86 patients with moderate to severe depression symptoms against a control group.

Leadership Team

  • Ben Lewis: Co-Founder & CEO of Limbix. Former Engineering Manager at Facebook.
  • Jon Sockell: Co-Founder & COO of Limbix. Former Director of Marketing at Motive.
  • Judy Liu: CTO at Limbix. Former Software Engineer at Facebook.
  • Aarthi Padmanabhan, Ph.D: Chief Research Officer at Limbix. Former Scientific Research Director at Stanford University School of Medicine.
  • Benjamin A.: Chief Medical Officer at Limbix. Former Senior Medical Director at Aetna.


People also viewed